https://e3ligasesignal.com/ind....ex.php/bioavailable-
EUS is an emerging tool that will distinguish between benign and malignant options that come with pancreatic cysts. We hoped to determine the precise cross-sectional imaging results and diligent characteristics that warrant EUS referral. PRACTICES We conducted a retrospective case-control chart analysis, evaluating customers, have been identified as having pancreatic cysts and underwent EUS between January 1, 2010 and December 31, 2017. RESULTS EUS
Me gusta
Comentario
Compartir
